Literature DB >> 27585738

Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression.

David G Harper1, J Eric Jensen1, Caitlin Ravichandran1, Roy H Perlis2, Maurizio Fava2, Perry F Renshaw3, Dan V Iosifescu4.   

Abstract

Brain bioenergetic abnormalities have been observed frequently in adults with major depressive disorder (MDD); however, results have been inconsistent regarding whether decreased or increased metabolism was observed. Phosphorus-31 magnetic resonance spectroscopy (31P MRS) allows for the quantification of bioenergetic molecules, containing high-energy phosphates, over the whole brain as well as measuring the differences between gray matter and white matter. We recruited 50 subjects with a current diagnosis of MDD, not currently treated with psychotropic medication, between ages of 18 and 65 (mean±SD age: 43.4±13.6; 46% female) and 30 healthy volunteers, matched for age and gender (39.0±12.5 years of age; 36.6% female). All subjects received a T1 MP-FLASH scan for tissue segmentation followed by 31P MRS, chemical shift imaging scan with 84 voxels of data collected over the entire brain utilizing a dual-tuned, proton-phosphorus coil to minimize subject movement. Phosphocreatine and inorganic phosphate (Pi) varied in opposite directions across gray matter and white matter when MDD subjects were compared with controls. This finding suggests alterations in high-energy phosphate metabolism and regulation of oxidative phosphorylation in MDD patients. In addition, within the MDD group, gray matter Pi, a regulator of oxidative phosphorylation, correlated positively with severity of depression. These data support a model that includes changes in brain bioenergetic function in subjects with major depression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27585738      PMCID: PMC5312061          DOI: 10.1038/npp.2016.180

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  44 in total

1.  Gatekeeping strategies for clinical trials that do not require all primary effects to be significant.

Authors:  Alexei Dmitrienko; Walter W Offen; Peter H Westfall
Journal:  Stat Med       Date:  2003-08-15       Impact factor: 2.373

2.  PHOSPHORYLCREATINE CONSUMPTION DURING SINGLE-WORKING CONTRACTIONS OF ISOLATED MUSCLE.

Authors:  A A INFANTE; D KLAUPIKS; R E DAVIES
Journal:  Biochim Biophys Acta       Date:  1965-03-29

3.  A symptom questionnaire.

Authors:  R Kellner
Journal:  J Clin Psychiatry       Date:  1987-07       Impact factor: 4.384

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  Evaluation of 31P metabolite differences in human cerebral gray and white matter.

Authors:  G F Mason; W J Chu; J T Vaughan; S L Ponder; D B Twieg; D Adams; H P Hetherington
Journal:  Magn Reson Med       Date:  1998-03       Impact factor: 4.668

6.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

Authors:  H S Mayberg; S K Brannan; J L Tekell; J A Silva; R K Mahurin; S McGinnis; P A Jerabek
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

7.  Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.

Authors:  John T Little; Terence A Ketter; Tim A Kimbrell; Robert T Dunn; Brenda E Benson; Mark W Willis; David A Luckenbaugh; Robert M Post
Journal:  Biol Psychiatry       Date:  2005-02-01       Impact factor: 13.382

Review 8.  A simple analysis of the "phosphocreatine shuttle".

Authors:  R A Meyer; H L Sweeney; M J Kushmerick
Journal:  Am J Physiol       Date:  1984-05

9.  Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.

Authors:  Dan V Iosifescu; Nicolas R Bolo; Andrew A Nierenberg; J Eric Jensen; Maurizio Fava; Perry F Renshaw
Journal:  Biol Psychiatry       Date:  2008-01-22       Impact factor: 13.382

10.  Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.

Authors:  J A Cobb; K O'Neill; J Milner; G J Mahajan; T J Lawrence; W L May; J Miguel-Hidalgo; G Rajkowska; C A Stockmeier
Journal:  Neuroscience       Date:  2015-12-30       Impact factor: 3.590

View more
  8 in total

1.  Rapid and simultaneous measurement of phosphorus metabolite pool size ratio and reaction kinetics of enzymes in vivo.

Authors:  Sang-Young Kim; Wei Chen; Dost Ongur; Fei Du
Journal:  J Magn Reson Imaging       Date:  2017-05-08       Impact factor: 4.813

2.  Chronic Social Stress Leads to Reduced Gustatory Reward Salience and Effort Valuation in Mice.

Authors:  Diana Kúkel'ová; Giorgio Bergamini; Hannes Sigrist; Erich Seifritz; Bastian Hengerer; Christopher R Pryce
Journal:  Front Behav Neurosci       Date:  2018-07-10       Impact factor: 3.558

3.  Cerebral bioenergetic differences measured by phosphorus-31 magnetic resonance spectroscopy between bipolar disorder and healthy subjects living in two different regions suggesting possible effects of altitude.

Authors:  Jaeuk Hwang; Lynn E DeLisi; Dost Öngür; Colin Riley; Chun Zuo; Xianfeng Shi; Young-Hoon Sung; Douglas Kondo; Tae-Suk Kim; Rosemond Villafuerte; Diane Smedberg; Deborah Yurgelun-Todd; Perry F Renshaw
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-03       Impact factor: 5.188

Review 4.  Creatine for the Treatment of Depression.

Authors:  Brent M Kious; Douglas G Kondo; Perry F Renshaw
Journal:  Biomolecules       Date:  2019-08-23

Review 5.  New Insights Into the Pivotal Role of CREB-Regulated Transcription Coactivator 1 in Depression and Comorbid Obesity.

Authors:  Clara Rossetti; Antoine Cherix; Laetitia F Guiraud; Jean-René Cardinaux
Journal:  Front Mol Neurosci       Date:  2022-02-15       Impact factor: 5.639

6.  Modifying the maternal microbiota alters the gut-brain metabolome and prevents emotional dysfunction in the adult offspring of obese dams.

Authors:  Daniel E Radford-Smith; Fay Probert; Philip W J Burnet; Daniel C Anthony
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 11.205

7.  Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder.

Authors:  Mhd Rami Al Shweiki; Patrick Oeckl; Petra Steinacker; Peggy Barschke; Cornelia Dorner-Ciossek; Bastian Hengerer; Carlos Schönfeldt-Lecuona; Markus Otto
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

8.  Dietary creatine intake and depression risk among U.S. adults.

Authors:  Amanda V Bakian; Rebekah S Huber; Lindsay Scholl; Perry F Renshaw; Douglas Kondo
Journal:  Transl Psychiatry       Date:  2020-02-03       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.